NCT02135042 2026-03-18
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
Phase 2/3 Active not recruiting
Clinical Trials
1 trialsActive not recruiting × Epstein-Barr Virus Infections × 1,2-diaminocyclohexaneplatinum II citrate × Clear all